eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..
..
exploding e-cigarette killed florida man, coroner says. it causes stroke and dementia as well as mood disturbance. svd increases with age but is accelerated by hypertension and diabetes.